Intra-Articular 0.5 % Lidocaine Injection for Osteoarthritis

NCT02632565 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2015-12-16

No results posted yet for this study

Summary

In this study, investigators compared the efficacy of intra-articular 0.5% lidocaine and saline injection on pain, stiffness and physical function in patients with osteoarthritis.

Conditions

Interventions

DRUG

Lidocaine

DRUG

Saline

Sponsors & Collaborators

  • Baskent University

    collaborator OTHER
  • H. Evren Eker

    lead OTHER

Principal Investigators

  • Anis Aribogan, Prof · Coordinator

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2015-03-31
Completion
2015-08-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02632565 on ClinicalTrials.gov